Page 3 - Alkermes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alkermes Today - Breaking & Trending Today

Alkermes plc: Alkermes to Participate in Two Upcoming Investor Conferences

DUBLIN, May 29, 2024 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences. Jefferies ....

United States , Jamie Constantine , Goldman Sachs , Annual Global Healthcare , Ihr Portfolio ,

Brokerages Set Alkermes plc (NASDAQ:ALKS) Target Price at $36.78

Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten analysts that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and six have given a buy recommendation to […] ....

United States , Christian Todd Nichols , Co Inc , Principal Financial Group Inc , Jefferies Financial Group , Cantor Fitzgerald , Allspring Global Investments Holdings , Get Free Report , Financial Group , Todd Nichols , Global Investments Holdings , Get Free , Alkermes Daily ,

Alkermes plc: Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024

- Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - - ....

United States , Craig Hopkinson , Gretchen Murphy , Michaelj Doane , Davidt Plante , Ron Grunstein , Sandy Coombs , University Of Wisconsin , Group Study Evaluating The Safety , Research Development At Alkermes , Woolcock Institute Of Medical Research , World Sleep Congress , Circadian Research , Breaking Abstracts Containing Data From , Full Narcolepsy Type , Design Accepted , Poster Presentations , From In Depth Qualitative Patient Interviews , Narcolepsy Will Also Be Presented , Associated Professional Sleep Societies , Wakefulness Test , Karolinska Sleepiness Scale , Chief Medical Officer , Executive Vice President , Pharmacodynamic Effects , Narcolepsy Type ,

Alkermes (NASDAQ:ALKS) Price Target Raised to $48.00

Alkermes (NASDAQ:ALKS – Free Report) had its price objective increased by Cantor Fitzgerald from $43.00 to $48.00 in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. Several other research analysts also recently commented on ALKS. HC Wainwright reaffirmed a neutral rating and issued […] ....

United States , Christian Todd Nichols , Principal Financial Group Inc , Alkermes Company Profile , Cantor Fitzgerald , Jefferies Financial Group , Allspring Global Investments Holdings , Jennison Associates , Securities Exchange Commission , Free Report , Financial Group , Get Free Report , Todd Nichols , Exchange Commission , Global Investments Holdings , Alkermes Daily ,

Dimensional Fund Advisors LP Has $66.67 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS)

Dimensional Fund Advisors LP grew its stake in Alkermes plc (NASDAQ:ALKS – Free Report) by 3.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,403,195 shares of the company’s stock after buying an additional 90,219 shares during the period. Dimensional Fund […] ....

United States , Christian Todd Nichols , Headlands Technologies , Cm Bidwell Associates Ltd , Mcglone Suttner Wealth Management Inc , Exchange Commission , Daiwa Securities Group Inc , Dimensional Fund Advisors , Jefferies Financial Group , Free Report , Fund Advisors , Glone Suttner Wealth Management , Securities Group , Get Free Report , Todd Nichols , Visit Holdingschannel , Alkermes Daily ,